Who invested in Semma Therapeutics?
Semma Therapeutics's investors include ARCH Venture Partners, F-Prime Capital, Medtronic, Eight Roads Ventures and MPM Capital, and 7 more on record.
United States · Series B startup
Funding summaryUpdated 26 Oct 2026
$158Mraised across 2 rounds since 2015, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by FinSMEsSEC filing: $54M sold, first sale Nov 2017
From a historical funding recordSEC filing: $15M sold, first sale Mar 2015
From the SEC filings it signed: 3 on the team.
On the board, as filediDaniel AuerbachKevin RaidyMark FishmanMitchell FinerStephen KnightWilliam Sahlman
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Semma Therapeutics's investors include ARCH Venture Partners, F-Prime Capital, Medtronic, Eight Roads Ventures and MPM Capital, and 7 more on record.
Semma Therapeutics has raised $158M across 2 rounds since 2015.
Semma Therapeutics's most recent round was a Series B of $114M in Nov 2017.
Its most recent round, $114M in Nov 2017, is also its largest on record.
Semma Therapeutics's first round on record, in Mar 2015, was backed by ARCH Venture Partners, F-Prime Capital and MPM Capital and 1 others.
Semma Therapeutics's latest named round is a Series B, in Nov 2017.
Semma Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.